Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPP.L Regulatory News (APP)

  • There is currently no data for APP

Rule 8.3- African Platinum

21 Feb 2007 15:13

UBS AG21 February 2007 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATIONName of person dealing (Note 1) UBS AG London Branch Company dealt in African Platinum PlcClass of relevant security to which the dealings Ord 0.1pbeing disclosed relate (Note 2)Date of dealing 20 February 2007 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 18,896,807 3.97% 0 0.00%(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal 18,896,807 3.97% 0 0.00% (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) PURCHASE 32,600 54.5p PURCHASE 967,400 54.5 PURCHASE 176,496 54.5 PURCHASE 50,000 54.5 PURCHASE 250,000 54.5 PURCHASE 500,000 54.5 (b) Derivatives transactions (other than options) Product name, Long/short (Note Number of securities Price per unit e.g. CFD 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities price American, date money paid/ call purchasing, to which European received option varying etc. the option etc. per unit relates (Note 5) (Note 7) (ii) ExercisingProduct name, e.g. Number of securities Exercise price per unit (Note 5)call option (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 21 February 2007 Contact name JOSEPH EVANS Telephone number 020 7567 8286 If a connected EFM, name of offeree/offeror with N/Awhich connectedIf a connected EFM, state nature of connection N/A(Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Mar 20237:00 amRNSCancellation - Appreciate Group plc
28th Feb 20232:27 pmGNWADMISSION OF CONSIDERATION SHARES
28th Feb 20231:00 pmRNSForm 8.3 - APPRECIATE GROUP PLC
28th Feb 202310:05 amRNSForm 8.3 - Appreciate Group plc / PayPoint plc
28th Feb 20239:05 amGNWPaypoint Completes Acquisition of Appreciate Group
28th Feb 20239:00 amRNSScheme of Arrangement becomes effective
28th Feb 20237:30 amRNSSuspension - Appreciate Group PLC
27th Feb 202310:06 amRNSForm 8.3 -APPRECIATE GROUP PLC
27th Feb 20239:44 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
24th Feb 20232:08 pmRNSForm 8.3 - Paypoint Plc
24th Feb 20231:33 pmRNSForm 8.3 - APPRECIATE GROUP PLC
24th Feb 202311:21 amRNSForm 8.3 - APPRECIATE GROUP PLC
24th Feb 20239:56 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
24th Feb 20239:33 amRNSForm 8.5 (EPT/RI)
24th Feb 20239:21 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
23rd Feb 202312:34 pmRNSExercise of Options
23rd Feb 202312:11 pmRNSForm 8.3 - APPRECIATE GROUP PLC
23rd Feb 202312:04 pmRNSCourt Sanction of the Scheme of Arrangement
23rd Feb 202311:10 amRNSForm 8.3 -APPRECIATE GROUP PLC
23rd Feb 20239:37 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
23rd Feb 20239:17 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
22nd Feb 20233:30 pmRNSForm 8.3 - APP LN
22nd Feb 20231:25 pmRNSForm 8.3 - APPRECIATE GROUP PLC
22nd Feb 20239:17 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
21st Feb 20235:45 pmRNSPayPoint
21st Feb 20234:01 pmRNSForm 8.3 - PAY LN
21st Feb 20234:00 pmRNSForm 8.3 - APP LN
21st Feb 202312:20 pmRNSForm 8.3 - APPRECIATE GROUP PLC
21st Feb 20239:18 amRNSForm 8.3 - Appreciate Group plc / PayPoint plc
20th Feb 20233:30 pmRNSForm 8.3 - PAY LN
20th Feb 20233:30 pmRNSForm 8.3 - APP LN
20th Feb 20238:48 amRNSForm 8.5 (EPT/RI)
17th Feb 20233:30 pmRNSForm 8.3 - APP LN
17th Feb 20232:55 pmRNSForm 8.3 - APPRECIATE GROUP PLC
16th Feb 20232:36 pmRNSForm 8.3 - PAYP LN
16th Feb 20232:35 pmRNSForm 8.3 - APP LN
16th Feb 202312:28 pmRNSForm 8.3 - APPRECIATE GROUP PLC
16th Feb 202310:09 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
16th Feb 20238:41 amRNSForm 8.3 - Appreciate Group PLC
15th Feb 20232:23 pmRNSForm 8.3 - APPRECIATE GROUP PLC
15th Feb 202310:30 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
15th Feb 20238:34 amRNSForm 8.5 (EPT/RI)
15th Feb 20238:33 amRNSForm 8.3 - APPRECIATE GROUP PLC
14th Feb 20235:12 pmRNSHolding(s) in Company
14th Feb 20232:38 pmRNSForm 8.3 - APPRECIATE GROUP PLC
14th Feb 20232:30 pmRNSForm 8.3 - APP LN
14th Feb 20239:38 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
14th Feb 20239:23 amRNSForm 8.5 (EPT/RI)
13th Feb 202311:50 amRNSForm 8.3 - Appreciate Group Plc
13th Feb 202311:43 amRNSForm 8.3 - APPRECIATE GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.